First demonstration of the effectiveness of peptide receptor radionuclide therapy (PRRT) with 111In-DTPA-octreotide in a giant PRL-secreting pituitary adenoma resistant to conventional treatment

Pituitary tumours: The sst/D2 receptors as molecular targets

(2010) Leo J. Hofland et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

MGMT immunoexpression in aggressive pituitary adenoma and carcinoma

(2010) Queenie Lau et al.   Pituitary

The prolactinoma

(2009) Annamaria Colao   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Giant Prolactinoma and Effectiveness of Medical Management

(2009) Shrikrishna Acharya et al.   Endocrine Practice

A novel use of temozolomide in a patient with malignant prolactinoma

(2009) Stephen Byrne et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Somatostatinergic ligands in dopamine-sensitive and -resistant prolactinomas

(2008) Alessandra Fusco et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY